American Cannabis Company Inc operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares American Cannabis Company Inc with three other
companies in this sector in UNITED STATES :
Celldex Therapeutics, Incorporation
sales of $3.57 million
of which 100%
was Novel Therapeutics),
Navidea Biopharmaceuticals Incorporated
of which 63%
was Diagnostics), and
of which 88%
was Product sales (own and third party)).
During the year ended December of 2019, sales at
American Cannabis Company Inc were $2.13 million.
increase of 116.9%
versus 2018, when the company's sales were $982,349.00 .
Despite this increase, sales are still
below the level achieved in 2017, when American Cannabis Company Inc
reported sales of $2.44 million.